Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A randomized, single-blind and parallel group study to compare the pharmacokinetic, safety and immunogenicity of HS-20090-2 60mg#1ml#and Prolia® in healthy adults.
Epistemonikos ID: bdbb1fe98e8d2fcb68dde8e3df8ff62d2e32f9fc
First added on: May 09, 2024